MedTrace Logo

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

NCT05181891 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 205

Last updated 2024-06-25

No results posted yet for this study

Summary

Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.

Conditions

  • Alcohol Use Disorder (AUD)
  • Nicotine Use Disorder

Interventions

BEHAVIORAL

Contingency Management

Incentives for submitting negative-alcohol urine samples

BEHAVIORAL

Non-contingent control

Incentives for submitting urine samples

Sponsors & Collaborators

  • Washington State University

    lead OTHER

Principal Investigators

  • Sterling M McPherson, PhD · Washington State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-11
Primary Completion
2026-05-01
Completion
2026-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05181891 on ClinicalTrials.gov